{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T02:15:23Z","timestamp":1793499323161,"version":"4.5.0"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n Identifying predictors of treatment toxicity and overall survival (OS) is important for selecting patients who will benefit from chemotherapy. In younger patients with cancer, muscle mass and radiodensity are associated with treatment toxicity and OS. In this study, we investigated whether muscle mass, radiodensity, and strength were associated with treatment toxicity and OS in patients with advanced cancer aged 60 years or older.<\/jats:p>\n <\/jats:sec>\n \n Materials and Methods<\/jats:title>\n Before starting palliative chemotherapy, muscle mass and radiodensity were assessed using computed tomography scans and muscle strength was assessed using a hydraulic hand grip dynamometer. Treatment toxicity was defined as any toxicity resulting in dose reduction and\/or discontinuation of treatment. Multiple logistic and Cox regression analyses were performed to study potential associations of muscle mass, radiodensity, and strength with treatment toxicity and OS, respectively.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The participants were 103 patients, with a mean age of 70 years, with advanced colorectal, prostate, or breast cancer. Muscle parameters were not significantly associated with treatment toxicity. Higher muscle strength was associated with longer OS (hazard ratio 1.03; 95% confidence interval 1.00\u20131.05). Muscle mass and radiodensity were not significantly associated with OS.<\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Higher muscle strength at the start of palliative chemotherapy is associated with significantly better OS in older patients with advanced cancer. None of the investigated muscle parameters were related to treatment toxicity. Future studies are needed to evaluate whether muscle strength can be used for treatment decisions in older patients with advanced cancer.<\/jats:p>\n <\/jats:sec>\n \n Implications for Practice<\/jats:title>\n This study in older patients with advanced cancer showed that adequate muscle strength is associated with longer overall survival. The results of this study imply that muscle strength might be helpful in estimating survival and therefore in identifying older patients who will benefit from anticancer treatment.<\/jats:p>\n <\/jats:sec>","DOI":"10.1634\/theoncologist.2017-0193","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T14:50:26Z","timestamp":1512744626000},"page":"580-585","source":"Crossref","is-referenced-by-count":74,"title":["Higher Muscle Strength Is Associated with Prolonged Survival in Older Patients with Advanced Cancer"],"prefix":"10.1093","volume":"23","author":[{"given":"Kathelijn Sophie","family":"Versteeg","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, VU University Medical Center (VUmc), Amsterdam, The Netherlands"},{"name":"Section of Gerontology and Geriatrics, Department of Internal Medicine, VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Blauwhoff-Buskermolen","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, VU University Medical Center (VUmc), Amsterdam, The Netherlands"},{"name":"Section of Nutrition and Dietetics, Department of Internal Medicine, VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurien M.","family":"Buffart","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, VU University Medical Center (VUmc), Amsterdam, The Netherlands"},{"name":"Department of Epidemiology and Biostatistics, EMGO Institute for Health and Care Research, VUmc, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian A.E.","family":"de van der Schueren","sequence":"additional","affiliation":[{"name":"Section of Nutrition and Dietetics, Department of Internal Medicine, VUmc, Amsterdam, The Netherlands"},{"name":"Faculty of Health and Social Studies, HAN University of Applied Sciences, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline A.E.","family":"Langius","sequence":"additional","affiliation":[{"name":"Section of Nutrition and Dietetics, Department of Internal Medicine, VUmc, Amsterdam, The Netherlands"},{"name":"Faculty of Health, Nutrition and Sport, The Hague University of Applied Sciences, The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk M.W.","family":"Verheul","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, VU University Medical Center (VUmc), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea B.","family":"Maier","sequence":"additional","affiliation":[{"name":"MOVE Research Institute Amsterdam, Department of Human Movement Sciences, VU University, The Netherlands"},{"name":"Department of Medicine and Aged Care, Royal Melbourne Hospital, University of Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge R.","family":"Konings","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, VU University Medical Center (VUmc), Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"2021122510451180900_onco12340-bib-0001","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s11606-010-1629-x","article-title":"Examining the evidence: A systematic review of the inclusion and analysis of older adults in randomized controlled trials","volume":"26","author":"Zullman","year":"2011","journal-title":"J Gen Intern Med"},{"key":"2021122510451180900_onco12340-bib-0002","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/annonc\/mdu052","article-title":"Prediction of treatment-related toxicity and outcome with geriatric assessment in elderly patients with solid malignancies treated with chemotherapy: A systematic review","volume":"25","author":"Versteeg","year":"2014","journal-title":"Ann Oncol"},{"key":"2021122510451180900_onco12340-bib-0003","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1002\/cncr.25370","article-title":"Predictors of competing mortality in early breast cancer","volume":"116","author":"Mell","year":"2010","journal-title":"Cancer"},{"key":"2021122510451180900_onco12340-bib-0004","first-page":"590","article-title":"Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer","volume":"307","author":"Water","year":"2012","journal-title":"JAMA"},{"key":"2021122510451180900_onco12340-bib-0005","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/bjs.7823","article-title":"Body composition and outcome of patients undergoing resection of colorectal liver metastases","volume":"99","author":"Vledder","year":"2012","journal-title":"Br J Surg"},{"key":"2021122510451180900_onco12340-bib-0006","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/gerona\/gls168","article-title":"Variations of CT-based trunk muscle attenuation by age, sex, and specific muscle","volume":"68","author":"Anderson","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2021122510451180900_onco12340-bib-0007","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: Skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin","year":"2013","journal-title":"J Clin Oncol"},{"key":"2021122510451180900_onco12340-bib-0008","doi-asserted-by":"crossref","first-page":"e29330","DOI":"10.1371\/journal.pone.0029330","article-title":"Body composition, symptoms, and survival in advanced cancer patients referred to a phase I service","volume":"7","author":"Parsons","year":"2012","journal-title":"PLoS One"},{"key":"2021122510451180900_onco12340-bib-0009","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"2021122510451180900_onco12340-bib-0010","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-08-2242","article-title":"Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment","volume":"15","author":"Prado","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2021122510451180900_onco12340-bib-0011","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/annonc\/mdp605","article-title":"Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma","volume":"21","author":"Antoun","year":"2010","journal-title":"Ann Oncol"},{"key":"2021122510451180900_onco12340-bib-0012","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.arr.2010.04.004","article-title":"Models of accelerated sarcopenia: Critical pieces for solving the puzzle of age-related muscle atrophy","volume":"9","author":"Buford","year":"2010","journal-title":"Ageing Res Rev"},{"key":"2021122510451180900_onco12340-bib-0013","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s11357-012-9384-z","article-title":"Defining sarcopenia: The impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort","volume":"35","author":"Bijlsma","year":"2013","journal-title":"Age (Dordr)"},{"key":"2021122510451180900_onco12340-bib-0014","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12603-009-0201-z","article-title":"Epidemiology and consequences of sarcopenia","volume":"13","author":"Abellan van Kan","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"2021122510451180900_onco12340-bib-0015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1477-2574.2011.00301.x","article-title":"Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis","volume":"13","author":"Peng","year":"2011","journal-title":"HPB (Oxford)"},{"key":"2021122510451180900_onco12340-bib-0016","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"2021122510451180900_onco12340-bib-0017","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"2021122510451180900_onco12340-bib-0018","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/gerona\/61.1.72","article-title":"Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort","volume":"61","author":"Newman","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2021122510451180900_onco12340-bib-0019","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1503\/cmaj.091278","article-title":"Handgrip strength and mortality in the oldest old population: The Leiden 85-plus study","volume":"182","author":"Ling","year":"2010","journal-title":"CMAJ"},{"key":"2021122510451180900_onco12340-bib-0020","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/ageing\/afq022","article-title":"Handgrip strength as a predictor of functional, psychological and social health. A prospective population-based study among the oldest old","volume":"39","author":"Taekema","year":"2010","journal-title":"Age Ageing"},{"key":"2021122510451180900_onco12340-bib-0021","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1007\/s00520-013-1894-4","article-title":"Handgrip strength predicts survival and is associated with markers of clinical and functional outcomes in advanced cancer patients","volume":"21","author":"Kilgour","year":"2013","journal-title":"Support Care Cancer"},{"key":"2021122510451180900_onco12340-bib-0022","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1093\/annonc\/mdu178","article-title":"Pre-cachexia\u201d: A non-existing phenomenon in cancer?","volume":"25","author":"Blauwhoff-Buskermolen","year":"2014","journal-title":"Ann Oncol"},{"key":"2021122510451180900_onco12340-bib-0023","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1200\/JCO.2015.63.6043","article-title":"Loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer","volume":"34","author":"Blauwhoff-Buskermolen","year":"2016","journal-title":"J Clin Oncol"},{"key":"2021122510451180900_onco12340-bib-0024","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol"},{"key":"2021122510451180900_onco12340-bib-0025","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1152\/jappl.1998.85.1.115","article-title":"Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography","volume":"85","author":"Mitsiopoulos","year":"1998","journal-title":"J Appl Physiol (1985)"},{"key":"2021122510451180900_onco12340-bib-0026","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/ageing\/23.2.132","article-title":"Maximal isometric strength and mobility among 75-year-old men and women","volume":"23","author":"Rantanen","year":"1994","journal-title":"Age Ageing"},{"key":"2021122510451180900_onco12340-bib-0027","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1152\/japplphysiol.00246.2003","article-title":"Age-associated changes in skeletal muscles and their effect on mobility: An operational diagnosis of sarcopenia","volume":"95","author":"Lauretani","year":"1985","journal-title":"J Appl Physiol"},{"key":"2021122510451180900_onco12340-bib-0028","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0001-2998(78)80014-2","article-title":"Basic principles of ROC analysis","volume":"8","author":"Metz","year":"1978","journal-title":"Sem Nucl Med"},{"key":"2021122510451180900_onco12340-bib-0029","doi-asserted-by":"crossref","first-page":"c4467","DOI":"10.1136\/bmj.c4467","article-title":"Objectively measured physical capability levels and mortality: Systematic review and meta-analysis","volume":"341","author":"Cooper","year":"2010","journal-title":"BMJ"},{"key":"2021122510451180900_onco12340-bib-0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/ije\/dyl224","article-title":"Grip strength, body composition, and mortality","volume":"36","author":"Gale","year":"2007","journal-title":"Int J Epidemiol"},{"key":"2021122510451180900_onco12340-bib-0031","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"2021122510451180900_onco12340-bib-0032","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000108386","article-title":"Do elderly cancer patients achieve an adequate dose intensity in common clinical practice?","volume":"71","author":"Luciani","year":"2006","journal-title":"Oncology"},{"key":"2021122510451180900_onco12340-bib-0033","first-page":"CD007146","article-title":"Interventions for preventing falls in older people living in the community","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122510451180900_onco12340-bib-0034","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00223-014-9907-y","article-title":"Long-term exercise in older adults: 4-year outcomes of music-based multitask training","volume":"95","author":"Hars","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"2021122510451180900_onco12340-bib-0035","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1200\/JCO.2014.59.1081","article-title":"Effect of low-intensity physical activity and moderate- to high-intensity physical exercise during adjuvant chemotherapy on physical fitness, fatigue, and chemotherapy completion rates: Results of the PACES randomized clinical trial","volume":"33","author":"Waart","year":"2015","journal-title":"J Clin Oncol"},{"key":"2021122510451180900_onco12340-bib-0036","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1080\/01635581.2014.894103","article-title":"Sarcopenia is linked to treatment toxicity in patients with metastatic colorectal cancer","volume":"66","author":"Barret","year":"2014","journal-title":"Nutr Cancer"},{"key":"2021122510451180900_onco12340-bib-0037","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/107327480701400105","article-title":"Pharmacokinetics of chemotherapy in the older patient","volume":"14","author":"Hurria","year":"2007","journal-title":"Cancer Control"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2017-0193","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2017-0193","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/23\/5\/580\/41915095\/oncolo_23_5_580.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/23\/5\/580\/41915095\/oncolo_23_5_580.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T10:48:03Z","timestamp":1640429283000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/23\/5\/580\/6439604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,12,8]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2017-0193","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5,1]]},"published":{"date-parts":[[2017,12,8]]}}}